Simplex Trading
WVE icon

Simplex Trading’s Wave Life Sciences WVE Stock Holding History

Simplex Trading’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$470K Sell
80,900
-40,600
-33% -$269K ﹤0.01% 3674
2026
Q1 		$881K Sell
121,500
-89,300
-42% -$1.16M ﹤0.01% 2642
2025
Q4 		$3.58M Buy
210,800
+128,800
+157% +$1.31M ﹤0.01% 1530
2025
Q3 		$600K Buy
82,000
+71,800
+704% +$581K ﹤0.01% 3600
2025
Q2 		$66K Sell
10,200
-72,900
-88% -$481K ﹤0.01% 5651
2025
Q1 		$671K Buy
83,100
+5,000
+6% +$54.7K ﹤0.01% 3076
2024
Q4 		$966K Buy
78,100
+43,800
+128% +$585K ﹤0.01% 2875
2024
Q3 		$281K Buy
+34,300
New +$205K ﹤0.01% 4197
2024
Q2 		– Sell
-2,300
Closed -$14K – 9971
2024
Q1 		$14K Sell
2,300
-25,200
-92% -$126K ﹤0.01% 7395
2023
Q4 		$138K Buy
27,500
+25,800
+1,518% +$138K ﹤0.01% 5057
2023
Q3 		$9K Buy
+1,700
New +$7.76K ﹤0.01% 7282
2023
Q2 		– Sell
-400
Closed -$1K – 10089
2023
Q1 		$1K Sell
400
-16,800
-98% -$77K ﹤0.01% 8799
2022
Q4 		$120K Buy
17,200
+2,300
+15% +$10.6K ﹤0.01% 4862
2022
Q3 		$53K Buy
14,900
+11,000
+282% +$36.4K ﹤0.01% 6381
2022
Q2 		$12K Buy
3,900
+2,600
+200% +$5K ﹤0.01% 8154
2022
Q1 		$2K Sell
1,300
-2,000
-61% -$4.9K ﹤0.01% 9959
2021
Q4 		$10K Sell
3,300
-9,200
-74% -$38.2K ﹤0.01% 9063
2021
Q3 		$84K Sell
12,500
-500
-4% -$3.03K ﹤0.01% 6871
2021
Q2 		$86K Buy
13,000
+12,933
+19,303% +$84.5K ﹤0.01% 6950
2021
Q1 		$37K Sell
67
-134
-67% -$1.29K ﹤0.01% 6947
2020
Q4 		$158K Sell
201
-349
-63% -$2.93K ﹤0.01% 4923
2020
Q3 		$466K Buy
550
+548
+27,400% +$6.01K ﹤0.01% 3088
2020
Q2 		$2K Sell
2
-292
-99% -$2.75K ﹤0.01% 7289
2020
Q1 		$275K Sell
294
-233
-44% -$1.99K ﹤0.01% 3232
2019
Q4 		$422K Buy
527
+526
+52,600% +$12.9K ﹤0.01% 2920
2019
Q3 		$2K Sell
1
-25
-96% -$573 ﹤0.01% 6966
2019
Q2 		$67K Buy
+26
New +$729 ﹤0.01% 4587

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Simplex Trading's WVE Position: Q2 2026 in Review

Simplex Trading reduced its Wave Life Sciences (WVE) stake by 82% in Q2 2026, selling an estimated $487K and leaving 15,792 shares worth $91.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5661.

Simplex Trading first reported a position in WVE in Q1 2019 and has held it in 25 quarters since. The position peaked at $647K in Q1 2026. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Simplex Trading held 15,792 shares of Wave Life Sciences worth $91.8K as of Q2 2026.
  • Simplex Trading sold 73,471 Wave Life Sciences shares in Q2 2026, an estimated $487K.
  • Wave Life Sciences made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5661 holding.
  • Simplex Trading first reported a position in Wave Life Sciences in Q1 2019 and has held it in 25 quarters since.
  • Simplex Trading's Wave Life Sciences position peaked at $647K in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.